Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots. The page content and structure appear unchanged, continuing to present the Study Details for NCT01415882.
    Difference
    0.2%
    Check dated 2025-10-28T02:50:23.000Z thumbnail image
  3. Check
    31 days ago
    Change Detected
    Summary
    Core content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T15:54:28.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    - Added revision tag v3.1.0 and removed the Plasma cell myeloma resource from the Genetic and Rare Diseases Information Center list. Overall: minor content update with a resource removal.
    Difference
    0.3%
    Check dated 2025-09-29T09:49:52.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Adds an estimated Last Update Posted and Revision: v3.0.2, replacing Last Update Posted and Revision: v3.0.1; also removes the Back to Top link.
    Difference
    0.1%
    Check dated 2025-09-14T23:55:45.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page has been updated to reflect the completion status of a study and the revision number has been incremented, indicating a new version of the document. Additionally, the identifier for the Mayo Clinic has been modified to remove the specific location reference.
    Difference
    1%
    Check dated 2025-09-07T20:38:41.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has added significant information regarding a facility and its location, as well as various medical compounds and treatments related to plasma cell myeloma, while removing several related topics and terms.
    Difference
    4%
    Check dated 2025-08-31T13:00:04.000Z thumbnail image

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.